Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer

NCT00220155 ↗

Phase 2 Completed 16 enrolled Royal Marsden NHS Foundation Trust

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the efficacy and safety of gemcitabine given by fixed dose rate intravenous infusion in patients with pretreated metastatic colorectal cancer.

Timeline

Start: 2004-05
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gemcitabine	Small molecule	—	Intravenous

Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer

Summary

Timeline

Drugs

Indications